Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders
NCT ID: NCT01143350
Last Updated: 2011-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
300 participants
INTERVENTIONAL
2010-03-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Primary efficacy criteria: Apathy Inventory clinician score changes
* Secondary efficacy criteria: Apathy Inventory patient and caregiver version changes, Observation scale changes, frequency and severity of the other BPSD using the NPI, qualitative analysis of the nursing home staff behavioural changes
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Care for Patients With Dementia
NCT03442322
Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy
NCT01384344
Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research
NCT01049555
Non Pharmacological Management of Behavioural Symptoms in Nursing Home
NCT00824967
Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases
NCT00833274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EHPAD Training and Stimulation
EHPAD of the group of Training / Stimulation will benefit:
* after a training in behaviours to be held or in methods of stimulation aiming at the reduction of disturbances of behaviour at type of apathy. This information will be transmitted in l 'ensemble of l 'équipe of l 'EHPAD by a training officer.
* of a structuring of the activities of animation offered to the inhabitants, This information will be regrouped in chips worked out like TNM - EHPAD.
Bras A (EHPAD Training and stimulation)
EHPAD of the group of Training / Stimulation will benefit:
* after a training in behaviours to be held or in methods of stimulation aiming at the reduction of disturbances of behaviour at type of apathy. This information will be transmitted in l 'ensemble of l 'équipe of l 'EHPAD by a training officer.
* of a structuring of the activities of animation offered to the inhabitants, This information will be regrouped in chips worked out like TNM - EHPAD.
2- EHPAD control
EHPAD of the reference group, will have their habitual functioning
EHPAD Control
EHPAD of the reference group, will have their habitual functioning
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bras A (EHPAD Training and stimulation)
EHPAD of the group of Training / Stimulation will benefit:
* after a training in behaviours to be held or in methods of stimulation aiming at the reduction of disturbances of behaviour at type of apathy. This information will be transmitted in l 'ensemble of l 'équipe of l 'EHPAD by a training officer.
* of a structuring of the activities of animation offered to the inhabitants, This information will be regrouped in chips worked out like TNM - EHPAD.
EHPAD Control
EHPAD of the reference group, will have their habitual functioning
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A diagnosis of dementia according to the ICD 10 criteria
* MMSE score ≤ 24
* Presenting the diagnostic criteria of apathy (cf page ??)
* An Apathy Inventory clinician total score \>3 (with at least a score higher than 1 at one of the 3 dimensions; lack of initiative, lack of interest, emotional blunting)
Exclusion Criteria
* MMSE score \> 24
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DRCI du CHU de Nice
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe Ph ROBERT, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU de Nice - CM2R - Hôpital de Cimiez - 4 avenue reine victoria - 06 003 Nice cedex 1
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert
Nice, Alpes-Maritimes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-PP-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.